Hana Must SPAC 2 (208370) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.013x

Based on the latest financial reports, Hana Must SPAC 2 (208370) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩838.06 Million ≈ $567.94K USD) by net assets (₩63.95 Billion ≈ $43.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hana Must SPAC 2 defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Hana Must SPAC 2 - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Hana Must SPAC 2's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hana Must SPAC 2 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hana Must SPAC 2 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Pan Global Resources Inc
V:PGZ
-0.282x
TPL Plastech Limited
NSE:TPLPLASTEH
0.277x
Aquila European Renewables Income PLC
LSE:AERI
N/A
IXAQF
NASDAQ:IXAQF
0.078x
Rent.com.Au Ltd
AU:RNT
-0.200x
Ionic Rare EARTHS Ltd
AU:IXR
-0.086x
Hankook Furniture Co. Ltd
KQ:004590
-0.025x
Daesung Hi-Tech Co. Ltd.
KQ:129920
0.072x

Annual Cash Flow Conversion Efficiency for Hana Must SPAC 2 (2015–2024)

The table below shows the annual cash flow conversion efficiency of Hana Must SPAC 2 from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see 208370 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩63.80 Billion
≈ $43.24 Million
₩4.50 Billion
≈ $3.05 Million
0.071x +22.09%
2023-12-31 ₩60.10 Billion
≈ $40.73 Million
₩3.47 Billion
≈ $2.35 Million
0.058x +3640.27%
2022-12-31 ₩32.89 Billion
≈ $22.29 Million
₩50.81 Million
≈ $34.43K
0.002x -98.52%
2021-12-31 ₩28.06 Billion
≈ $19.02 Million
₩2.93 Billion
≈ $1.98 Million
0.104x -38.53%
2020-12-31 ₩24.89 Billion
≈ $16.87 Million
₩4.23 Billion
≈ $2.86 Million
0.170x +11.18%
2019-12-31 ₩24.14 Billion
≈ $16.36 Million
₩3.69 Billion
≈ $2.50 Million
0.153x +132.33%
2018-12-31 ₩14.60 Billion
≈ $9.90 Million
₩-6.90 Billion
≈ $-4.67 Million
-0.472x -205.32%
2017-12-31 ₩27.81 Billion
≈ $18.85 Million
₩-4.30 Billion
≈ $-2.92 Million
-0.155x +33.13%
2016-12-31 ₩26.92 Billion
≈ $18.24 Million
₩-6.23 Billion
≈ $-4.22 Million
-0.231x -2788.35%
2015-12-31 ₩19.09 Billion
≈ $12.94 Million
₩164.29 Million
≈ $111.33K
0.009x --

About Hana Must SPAC 2

KQ:208370 Korea Medical Devices
Market Cap
$56.64 Million
₩83.58 Billion KRW
Market Cap Rank
#21489 Global
#1256 in Korea
Share Price
₩3250.00
Change (1 day)
-3.13%
52-Week Range
₩2975.00 - ₩6650.00
All Time High
₩12885.20
About

SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The compa… Read more